Follow-up of the use of metformin among the high risk population;Seguimiento de la utilización de metformina en la población de riesgo

Farmacia Hospitalaria

Volumn 29, Issue 6, 2005, Pages 364-366

  Capafons, Susana Redondo ^a   Garriga Biosca, M R ^a   Pla Poblador, R ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Follow up; Metformin; Use

Indexed keywords

METFORMIN;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; DIARRHEA; DRUG USE; DRUG UTILIZATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; KIDNEY FUNCTION; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PROSPECTIVE STUDY; SIDE EFFECT;

EID: 32244433103     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(05)73697-7     Document Type: Article

References (10)

1. Turner RC, Holman RR, Stratton IM, Cull CA, Matthews DR, Manley SE, et al, for the UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-65.
2. Goday Arno A, Franch Nadal J, Mata Cases M. Criterios de control y pautas de tratamiento combinado en la diabetes tipo 2. Actualización 2004. Med Clin 2004; 123: 187-97.
3. Khan JK, Pallaki M, Tolbert SR, Hornick TR. Lactic acidemia associated with metformin. Ann Pharmacother 2003; 37: 66-9.
4. Solano Remírez M, Gonzalez Arencibia C, Álvarez Frías M, Llorente Díaz B, Echegaray Agara M. Acidosis láctica en paciente tratado con metformina. An Med Interna 2004; 21: 288-90.
5. Dawson D, Conlon C. Case study: metformin associated lactic acidosis. Diabetes Care 2003; 26: 2471-2.
6. Fernández Fernández I. La rehabilitación de la metformina. Aten Primaria 2005; 36: 183-93.
7. Metformina. Ficha técnica.
8. Sáenz Calvo A, Fernández Esteban I, Mataix Sanjuán A, Ausejo Segura M, Roqué M, Moher D. Metformina para la diabetes mellitus tipo 2. Revisión sistemática y metanálisis. Aten Primaria 2005; 36: 183-93.
9. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2002; (2): CD002967.
10. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Systematic review and meta-analysis. Arch Intern Med 2003; 163: 2594-602.